These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. GSK-3beta and control of glucose metabolism and insulin action in human skeletal muscle. Ciaraldi TP; Carter L; Mudaliar S; Henry RR Mol Cell Endocrinol; 2010 Feb; 315(1-2):153-8. PubMed ID: 19505532 [TBL] [Abstract][Full Text] [Related]
5. Pharmacological inhibitors of glycogen synthase kinase 3. Meijer L; Flajolet M; Greengard P Trends Pharmacol Sci; 2004 Sep; 25(9):471-80. PubMed ID: 15559249 [TBL] [Abstract][Full Text] [Related]
6. Deletion of glycogen synthase kinase-3β in cartilage results in up-regulation of glycogen synthase kinase-3α protein expression. Gillespie JR; Ulici V; Dupuis H; Higgs A; Dimattia A; Patel S; Woodgett JR; Beier F Endocrinology; 2011 May; 152(5):1755-66. PubMed ID: 21325041 [TBL] [Abstract][Full Text] [Related]
7. Glycogen synthase kinase-3 beta inhibitor suppresses Porphyromonas gingivalis lipopolysaccharide-induced CD40 expression by inhibiting nuclear factor-kappa B activation in mouse osteoblasts. Die L; Yan P; Jun Jiang Z; Min Hua T; Cai W; Xing L Mol Immunol; 2012 Aug; 52(1):38-49. PubMed ID: 22580404 [TBL] [Abstract][Full Text] [Related]
8. Effects of mutations in Wnt/β-catenin, hedgehog, Notch and PI3K pathways on GSK-3 activity-Diverse effects on cell growth, metabolism and cancer. McCubrey JA; Rakus D; Gizak A; Steelman LS; Abrams SL; Lertpiriyapong K; Fitzgerald TL; Yang LV; Montalto G; Cervello M; Libra M; Nicoletti F; Scalisi A; Torino F; Fenga C; Neri LM; Marmiroli S; Cocco L; Martelli AM Biochim Biophys Acta; 2016 Dec; 1863(12):2942-2976. PubMed ID: 27612668 [TBL] [Abstract][Full Text] [Related]
9. Crosstalk between NF-kappaB/p65 and beta-catenin/TCF4/p300 signalling pathways through alterations in GSK-3beta expression during trans-differentiation of endometrial carcinoma cells. Saegusa M; Hashimura M; Kuwata T; Hamano M; Okayasu I J Pathol; 2007 Sep; 213(1):35-45. PubMed ID: 17607667 [TBL] [Abstract][Full Text] [Related]
10. Distinct molecular regulation of glycogen synthase kinase-3alpha isozyme controlled by its N-terminal region: functional role in calcium/calpain signaling. Azoulay-Alfaguter I; Yaffe Y; Licht-Murava A; Urbanska M; Jaworski J; Pietrokovski S; Hirschberg K; Eldar-Finkelman H J Biol Chem; 2011 Apr; 286(15):13470-80. PubMed ID: 21266584 [TBL] [Abstract][Full Text] [Related]
11. Glycogen synthase kinase 3beta-mediated serine phosphorylation of the human glucocorticoid receptor redirects gene expression profiles. Galliher-Beckley AJ; Williams JG; Collins JB; Cidlowski JA Mol Cell Biol; 2008 Dec; 28(24):7309-22. PubMed ID: 18838540 [TBL] [Abstract][Full Text] [Related]
14. Glycogen synthase kinase-3β is a crucial mediator of signal-induced RelB degradation. Neumann M; Klar S; Wilisch-Neumann A; Hollenbach E; Kavuri S; Leverkus M; Kandolf R; Brunner-Weinzierl MC; Klingel K Oncogene; 2011 May; 30(21):2485-92. PubMed ID: 21217772 [TBL] [Abstract][Full Text] [Related]
15. GSK-3β and vitamin D receptor are involved in β-catenin and snail signaling in high glucose-induced epithelial-mesenchymal transition of mouse podocytes. Guo J; Xia N; Yang L; Zhou S; Zhang Q; Qiao Y; Liu Z Cell Physiol Biochem; 2014; 33(4):1087-96. PubMed ID: 24732862 [TBL] [Abstract][Full Text] [Related]
16. 4-Aminoethylamino-emodin--a novel potent inhibitor of GSK-3beta--acts as an insulin-sensitizer avoiding downstream effects of activated beta-catenin. Gebhardt R; Lerche KS; Götschel F; Günther R; Kolander J; Teich L; Zellmer S; Hofmann HJ; Eger K; Hecht A; Gaunitz F J Cell Mol Med; 2010 Jun; 14(6A):1276-93. PubMed ID: 19228266 [TBL] [Abstract][Full Text] [Related]
17. Genetic deletion of glycogen synthase kinase-3beta abrogates activation of IkappaBalpha kinase, JNK, Akt, and p44/p42 MAPK but potentiates apoptosis induced by tumor necrosis factor. Takada Y; Fang X; Jamaluddin MS; Boyd DD; Aggarwal BB J Biol Chem; 2004 Sep; 279(38):39541-54. PubMed ID: 15252041 [TBL] [Abstract][Full Text] [Related]
18. Selective small molecule inhibitors of glycogen synthase kinase-3 modulate glycogen metabolism and gene transcription. Coghlan MP; Culbert AA; Cross DA; Corcoran SL; Yates JW; Pearce NJ; Rausch OL; Murphy GJ; Carter PS; Roxbee Cox L; Mills D; Brown MJ; Haigh D; Ward RW; Smith DG; Murray KJ; Reith AD; Holder JC Chem Biol; 2000 Oct; 7(10):793-803. PubMed ID: 11033082 [TBL] [Abstract][Full Text] [Related]